肿瘤医院腾退 中珠医疗年度业绩预亏超亿元

Core Viewpoint - Zhongzhu Medical Holdings Co., Ltd. expects a net profit loss of 100 million to 150 million yuan for the year, with a loss of 110 million to 160 million yuan after excluding non-recurring gains and losses [1][4]. Group 1: Reasons for Loss - The anticipated loss is primarily due to two factors: the impact of the real estate market environment leading to a decline in property prices, resulting in significant asset impairment losses from commercial assets and substantial bad debt provisions for other receivables from joint ventures in commercial real estate projects [4]. - Additionally, the Beijing Loyal Oncology Hospital project has been unable to operate normally, leading to losses, and the company is currently executing a court ruling for its vacating [5]. Group 2: Company Background - Zhongzhu Medical was listed on the Shanghai Stock Exchange in May 2001, with its main business activities including pharmaceutical manufacturing, medical services, medical devices, and real estate [5]. - Zhongzhu Jun Tian (Beijing) Medical Technology Co., Ltd. is a subsidiary of Zhongzhu Medical and is the parent company of Beijing Loyal Oncology Hospital, which has been in a state of pending operation due to disputes over lease contracts and construction contracts since October 2022 [5].